编辑视角：基因编辑板块波动中，EDIT在GF Value™上高估34.1%
· gurufocus.com
2026年9月23日，Editas Medicine Inc（纳斯达克：EDIT）股价下跌近5%，此前Anthropic宣布了一种类似CRISPR的新型酶系统。
On September 23, 2026, Editas Medicine Inc (NASDAQ: EDIT) shares declined nearly 5% following Anthropic’s announcement of a novel CRISPR-like enzyme system di...